NRGENE TECHNOLOGIES LTD

As of June 30, 2026, NRGENE TECHNOLOGIES LTD carries a market capitalization of 2.86B, placing it among publicly traded companies globally. Its enterprise value stands at 1.96B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, NRGENE TECHNOLOGIES LTD has 13.27M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, NRGENE TECHNOLOGIES LTD maintains a current ratio of 0.84, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, NRGENE TECHNOLOGIES LTD's stock has declined approximately 76.64% over the past 52 weeks. The 50-day moving average sits at 135.70, while the 200-day moving average is 220.04.

As of June 30, 2026, NRGENE TECHNOLOGIES LTD holds 928.31M in cash and equivalents against 43.27M in total debt, resulting in a net debt position of -928.31M. Total book value stands at 748.10M, with working capital of -219.93M providing operational flexibility.